Skip to main content
Equibles

Assenagon Asset Management S.A.

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1546007 SENNINGERBERG, N4
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 21, 2026
Position Value
$11,182,795
+$845,180 QoQ
Shares Held
308,917
-1.2% QoQ
Ownership
0.949%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#29
of 280 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. COLL ranks #9 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 3,056,017 $103,537,855
2 LNTH
Lantheus Holdings, Inc.
 714,980 $79,319,881
3 VTRS
Viatris Inc
 4,989,006 $79,225,415
4 INDV
Indivior Pharmaceuticals, Inc.
 1,540,928 $63,224,275
5 UTHR
UNITED THERAPEUTICS Corp
 84,538 $45,805,224
6 AMRX
Amneal Pharmaceuticals, Inc.
 2,445,549 $42,332,453
7 NBIX
Neurocrine Biosciences Inc
 222,606 $37,518,015
8 ZTS
Zoetis Inc.
 389,335 $27,977,613

All Filings in COLL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,182,795 308,917
2026-03-31 $10,337,615 312,598
2025-12-31 $23,691,617 511,698
2025-09-30 $6,843,659 195,589
2025-06-30 $3,036,572 102,691
2025-03-31 $3,065,326 102,691
2024-12-31 $4,314,346 150,588
2024-09-30 $6,712,308 173,714
2024-06-30 $11,660,811 362,137
2024-03-31 $2,750,435 70,851
2023-12-31 $10,644,955 345,840
2023-09-30 $9,512,830 425,630
2023-06-30 $3,289,366 153,065
2023-03-31 $6,205,973 258,690
2022-12-31 $3,079,428 132,734
2022-09-30 $237,640 14,834
2022-06-30 $893,052 50,398
2022-03-31 $1,026,103 50,398